Adapted HOPE workshop to reduce burnout for gynecologic oncology clinicians
Adaptation of Helping Ovarian Cancer Patients Cope (HOPE) for Clinician Burnout (HOPE-C)
NA · Fred Hutchinson Cancer Center · NCT07282158
This program will test whether an adapted HOPE workshop can help gynecologic oncology clinicians reduce stress and burnout.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fred Hutchinson Cancer Center (other) |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT07282158 on ClinicalTrials.gov |
What this trial studies
The protocol adapts the Helping Ovarian Cancer Patients Cope (HOPE) workshop for clinicians, focusing on narrative reframing, peer support, and meaning-making. Clinicians first review intervention materials and provide feedback via interviews and questionnaires during a development phase. A pilot phase has participants attend four weekly 30–45 minute HOPE-C sessions and complete questionnaires before and after the sessions. Participants may also be interviewed after completing the intervention to gather qualitative feedback.
Who should consider this trial
Good fit: Ideal participants are English-speaking clinicians aged 18 or older who work with ovarian cancer patients (gynecologic oncologists, medical oncologists, nurses, social workers, and advanced practice providers) and can provide informed consent.
Not a fit: Clinicians who do not work with ovarian cancer patients, who cannot participate in brief weekly sessions, or who are non-English speakers may not receive benefit from this intervention.
Why it matters
Potential benefit: If successful, the intervention could lower clinician burnout and improve well-being, which may indirectly improve patient care and reduce errors.
How similar studies have performed: The original HOPE workshop has shown positive effects on hope and coping in ovarian cancer patients, and narrative or peer-support approaches have shown some success reducing clinician burnout, but applying HOPE to clinicians is a novel adaptation with limited prior testing.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years of age or older * English speaking * Able to provide informed consent * Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers \[APPs\])
Where this trial is running
Seattle, Washington
- Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States (RECRUITING)
Study contacts
- Principal investigator: Megan J. Shen, PhD — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Megan J. Shen, PhD
- Email: mshen2@fredhutch.org
- Phone: 206-667-4172
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ovarian Carcinoma, Psychiatric Disorder